HighLife
French tech company | Builders Republic
About
Medtech company developing a transcatheter mitral valve replacement (TMVR) system for patients with mitral regurgitation who cannot undergo open-heart surgery — a two-component valve-in-ring design (a sub-annular ring and a bovine-pericardium valve) implanted on a beating heart via a transfemoral, transseptal route.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series C
- Founded
- 2010
- City
- PARIS
- Region
- IDF
- Tracked rounds
- 5
- Amount raised
- ≥ 129 M€
Operations
- Series C · 2026
- Extension · 2020
- Series B · 2019
- Series A · 2017
- Seed · 2012
Investors
- Andera Partners
- BNP Paribas Développement
- Capricorn Venture Partners
- Critical Path Ventures
- LivaNova
- Merieux Partners
- Pro Benefis Familiae
- Sectoral Asset Management
- Sofinnova
- SPRIM Global Investments
- Supernova Invest
- US Venture Partners
- VI Partners